Trump Media & Technology Group (NASDAQ: DJT), the company behind Truth Social, witnessed a sharp surge on Election Day, with shares climbing as traders bet that a second Trump presidency could reignite business prospects. The stock, often regarded as a proxy for the former president’s White House chances, has seen heavy retail interest, especially on platforms like WallStreetBets, where it topped discussions, opening the way to small cap stocks some mentioned herein. 

Trump Media & Technology (NASDAQ: DJT), the operator of Truth Social, surged on Election Day, as traders speculated that a second Trump presidency could boost its business prospects. Seen as a proxy for Trump’s potential return to the White House. Despite a 33% drop last week, DJT rose 12% on Monday and gained 16.8% today in early trading. “We are trading this like GameStop (NYSE: GME) on steroids right now,” said Jay Woods, chief capital strategist at Freedom Capital Markets, on CNBC Monday. Retail interest remains high, with DJT topping discussions on WallStreetBets, though analysts caution that its long-term metrics lack fundamental support. 

Cardiol Therapeutics Inc. (NASDAQ: CRDL) is developing CardiolRx™ positioned as a treatment for myocarditis, a serious inflammation of the heart muscle often linked to viral infections, among other health conditions. Myocarditis can lead to severe complications, including heart failure, arrhythmias, and even sudden cardiac death to people of all ages. By leveraging its expertise in developing anti-inflammatory therapies, Cardiol Therapeutics seeks to improve patient outcomes at risk of heart-related complications due to inflammation.

Avalon GloboCare (NASDAQ: ALBT) has appointed Dr. Charles Cavo to its Advisory Board to advance the marketing of KetoAir™, a handheld breathalyzer for ketosis monitoring. With expertise in obesity and metabolic health, Dr. Cavo, co-founder of Pounds Transformation, will support strategic partnerships and guide KetoAir™'s business plan. Designed for real-time metabolic insights, KetoAir™ aids weight management and conditions like diabetes by measuring adherence to ketogenic diets, aligning with the growing relevance of GLP-1-based dietary approaches. 

ZyVersa Therapeutics (Nasdaq: ZVSA) has highlighted new data showing that inhibiting the NLRP3 inflammasome can protect pancreatic islet beta cells, potentially slowing the progression from obesity to insulin resistance and type 2 diabetes. Published in the International Journal of Nanomedicine, the study demonstrated that inflammasome inhibition preserved beta cell function and improved metabolic health in an obesity mouse model. These findings support ZyVersa’s development of its Inflammasome ASC Inhibitor IC 100, intended as an add-on to incretin therapy for treating obesity-related metabolic conditions.

Peraso Inc. (NASDAQ: PRSO), a leader in wireless technology, announced agreements for the immediate exercise of certain Series B warrants, allowing the purchase of 2,246,030 shares of common stock at a reduced price of $1.30 per share. This exercise is expected to generate $2.9 million in gross proceeds, and a new strong trading market at a range reflecting the $1.30 warrant exercise price is emerging. Ladenburg Thalmann & Co. Inc. serving as the exclusive placement agent for this offering.

With continued strong retail support and ongoing market momentum, Trump Media & Technology (NASDAQ: DJT) remains a focal point for traders eyeing political trends, though experts warn about the risks tied to its fundamentals.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com